NPPA computed the Retail Price of Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg + Glimepiride IP 2mg + Metformin Hydrochloride IP 1000mg (as Extended release) for M/s Mascot Health Series Pvt. Ltd. (Manufacturer) & M/s USV Ltd. (Marketer)

Feb 25, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific Compliance

The National Pharmaceutical Pricing Authority (NPPA) on February 24, 2025, issued the Computation of Retail Price of Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg + Glimepiride IP 2mg + Metformin Hydrochloride IP 1000mg (as Extended release) for M/s Mascot Health Series Pvt. Ltd. (Manufacturer) & M/s USV Ltd. (Marketer).

The following has been stated namely: -

• The Retail Price has been computed based on the data from June, 2024

• The Retail Price has been computed for Each Film Coated Tablet Containing Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg + Glimepiride IP 2mg + Metformin Hydrochloride IP 1000mg (as Extended release) for M/s Mascot Health Series Pvt. Ltd. (Manufacturer) & M/s USV Ltd. (Marketer).

• The Total MAT is 1,71,97,725


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT